ORAGENICS, INC. Convertible Notes Payable, Current
ORAGENICS, INC. (OGEN) had Convertible Notes Payable, Current of $5.00 million as of 2015-09-30, per its 10-Q filed 2015-11-06.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2015-11-06
- 2015-09-30: Convertible Notes Payable, Current $5.00M.
- 2015-06-30: Convertible Notes Payable, Current $5.00M.
- 2013-09-30: Convertible Notes Payable, Current $1.96M.
- 2011-12-31: Convertible Notes Payable, Current $7.50M.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2015-09-30 | $5.00M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $5.00M 10-Q · filed 2015-08-07 |
| 2013-09-30 | $1.96M 10-Q · filed 2013-10-25 |
| 2011-12-31 | $7.50M 10-K · filed 2013-03-26 |
| 2011-09-30 | $6.00M 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |